Atlas Trials

A Single Dose Safety, Tolerability, Pharmacokinetic and Food Effect Study of KVD900 (Sebetralstat) in Healthy Volunteers

Clinical trial NCT04349800 · COMPLETED

Trial details

NCT number
NCT04349800
Sponsor
KalVista Pharmaceuticals, Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hereditary Angioedema
Start date
2018-01-04
Primary completion
2018-09-10
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.